20 分钟on MSN
Sneaky senescent cells that resist cancer treatment can provide druggable lung cancer target
Senescent fibroblasts are aging cells that no longer divide and protect against tumor development. Yet two decades have gone ...
Superficially, gene flow between dingoes and European dogs sounds like a negative outcome. Our research, however, suggests ...
Researchers examined five AI models on multiple genomic tasks to see how well they performed. The findings provide a ...
This was not the first presentation on STI-571, but it was the one that would change everything: The New England Journal of ...
This study presents a large, systematically curated catalog of non-canonical open reading frames (ncORFs) in human and mouse by reanalyzing nearly 400 Ribo-seq datasets using a standardized pipeline; ...
Take a deep breath . Seems harmless, doesn rsquo;t it? Yet, with every breath, you might be inhaling something far more ...
Junevity, a biotechnology company on a mission to extend lifespan and healthspan with cell reprogramming, raised $10 million in new funding, bringing its Seed financing to a total of $20 million. The ...
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, today announced changes to its Board of Directors, including the departure of two directors and the appointment of a new ...
VTx-002 is described as a first-in-class vectorised antibody targeting molecular pathways involving TAR DNA-binding protein ...
A study published in the journal Scientific Reports highlights a protein called Claudin-4, which is found in higher amounts ...
Now, scientists at the University of Kentucky, along with other researchers, have made an exciting discovery. They found that ...
EVE combines evolutionary insights with human population data to identify damaging genetic mutations, improving variant ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈